Recorded Chinese product: 盐酸曲美他嗪片盐酸曲美他嗪片
This is a medicine registration record from NMPA data.本页为国家药监局药品注册记录。
Labeled sections from the recorded Chinese source are included below. English wording is a reference translation when one is on file, not an official English label.本记录未接入产品级适应症/安全性标注字段。
生产企业Manufacturer
- 湖北四环制药有限公司Chinese legal name: 湖北四环制药有限公司
主要成分Active Ingredients
- 曲美他嗪Qumei Taqin
药物知识说明
曲美他嗪是一种在国家药监局注册认定的药品。该药品含有曲美他嗪-25cb3db2等成分。
该药品关联的活性成分包括：曲美他嗪Qumei Taqin。这些成分信息来自国家药监局数据库。
该药品标注的生产企业为：湖北四环制药有限公司Chinese legal name: 湖北四环制药有限公司。
您可以探索含有相同成分的其他药品：曲美他嗪-25cb3db2成分药品。
本页面内容来自国家药监局数据库，MedicineGraph在此基础上提供关系图谱和知识导航。
Medicine Knowledge
This medicine (original name: 盐酸曲美他嗪片) is a medicine registered with the national drug regulatory authority. It contains recorded ingredients as active ingredient(s).
Active ingredients associated with this product: 曲美他嗪Qumei Taqin.
Manufacturers recorded for this product: 湖北四环制药有限公司Chinese legal name: 湖北四环制药有限公司.
Explore other medicines containing the same ingredient: 曲美他嗪 productsProducts containing this recorded ingredient.
Source: MedicineGraph authoritative database. Relationships derived from registered product information.
这是什么What is this
- 通用名/品名Recorded product name: 盐酸曲美他嗪片Recorded Chinese product: 盐酸曲美他嗪片
- 剂型Dosage form: 片剂Tablets
- 规格Specification: 20mg*24片20 mg × 24 tablets
本段仅展示注册/说明书已记录的身份属性，不含适应症或用法建议。Identity attributes from registration/leaflet records only; no indications or usage advice.
主要成分Ingredients
生产企业Manufacturer
- 湖北四环制药有限公司Chinese legal name: 湖北四环制药有限公司
注册信息NMPA approval number
- 批准文号NMPA approval number: 国药准字H20083596
关联实体Relationships
信息来源Source and scope
国家药品监督管理局（中国）药品注册数据及已接入说明书字段。National Medical Products Administration (China) medicine-registration data and linked leaflet fields.
- 品名来源Name source: 10多万条药品说明书数据库 (HIGH)Package-insert database (more than 100,000 records) (HIGH)
- 生产企业来源Manufacturer source: 10多万条药品说明书数据库Package-insert database (more than 100,000 records)
- 剂型来源Dosage-form source: 10多万条药品说明书数据库Package-insert database (more than 100,000 records)
范围：当前 MedicineGraph 注册记录及已记录的精确关系；非完整目录，亦不构成疗效等同主张，也不支持换用判断。不含适应症/安全性推断。Scope: current MedicineGraph registration records and exact recorded relationships; not a complete catalog and not a claim of therapeutic equivalence. No inferred indications/safety.
本段为已核准说明书原文摘录（非改写、非AI摘要），非正式英文标签，亦不构成用药建议。 Not an official English label and not medical advice. English wording, when shown, is a reference translation of the Chinese source label.
English translation for reference. Translated from the Chinese source label. Not an official English label and not medical advice.
NMPA approval number
国药准字H20083596
Manufacturer
Chinese legal name: 湖北四环制药有限公司 (domestically manufactured)
Indications
English translation unavailable. The original Chinese source label remains available below.
Dosage and administration
English translation unavailable. The original Chinese source label remains available below.
Adverse reactions
English translation unavailable. The original Chinese source label remains available below.
Contraindications
English translation unavailable. The original Chinese source label remains available below.
Precautions
English translation unavailable. The original Chinese source label remains available below.
Storage
English translation unavailable. The original Chinese source label remains available below.
Specification
20 mg × 24 tablets
中文说明书原文Original Chinese source label
批准文号
国药准字H20083596
生产企业
湖北四环制药有限公司(国产)
适应症
本品用于心绞痛发作的预防性治疗，眩晕和耳鸣的辅助性对症治疗。
用法用量
每24小时60mg(3片)：每日3次，每次1片，三餐时服用。
不良反应
1. 罕见胃肠道不适（恶心，呕吐）。
2.极罕见帕金森症状，如震颤、强直和运动不能，停药后可恢复。
3. 由于辅料中有日落黄FCF S (Ell0)及胭脂红A(E124)成份，可能会发生过敏反应。
禁忌
1.对药品任一组份过敏者禁用。
2.哺乳期通常不推荐使用(参见孕妇及哺乳期妇女用药)。
注意事项
1.此药不作为心绞痛发作时的对症治疗用药，也不适用于对不稳定心绞痛或心肌梗死的初始治疗。
2.此药不应用于入院前或入院后最初几天的治疗。
3.心绞痛发作时，对冠状动脉病况应重新评估，并考虑治疗的调整(药物治疗和可能的血运重建)。
贮藏
密封，在干燥处保存。
规格
20mg*24片
信息来源Source and scope
国家药品监督管理局（中国）药品注册数据。National Medical Products Administration (China) medicine-registration data.
范围：当前 MedicineGraph 注册记录及已记录的精确关系；非完整目录，亦不构成疗效等同主张，也不支持换用判断。Scope: current MedicineGraph registration records and exact recorded relationships; not a complete catalog and not a claim of therapeutic equivalence.